Patient P-01631
Synthetic patientNBL-101 · Day 112 · 65–74 · F · baseline S14Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Improving
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
63%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S14
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- GI instability+26
- Inflammatory activity+11
- Nutritional resilience-7
- Toxicity-5
- Treatment adherence+4
What helped?
No interventions yet.
LIFE OS recommendation
Clinician Review CR-01
77%
probability of meaningful tolerance improvement
- 284 similar trajectories
- 100% showed improvement
- median effect visible after 5 days
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion35.9/100
improving · -4.0 vs previous 14 d
Toxicity
Blood16.4/100
improving · -6.4 vs previous 14 d
Sleep quality
Wearable24/100
improving · +3.5 vs previous 14 d
Energy level
Daily log5.1/10
improving · +0.3 vs previous 14 d
Stress level
Daily log4.6/10
stable · -0.1 vs previous 14 d
Steps
Wearable1,223
worsening · -286 vs previous 14 d
Adherence
Companion93.1 %
improving · +4.0 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 58 from the failing basin, 29 from restoration.
Would help
- ME-01 Monitoring Escalation100% improved among 12 similar · onset 3 d · confidence 65%
Would not help
- HY-01 Hydration Protocolonly 40% improved among 10 similar
- Keep alcohol lowGI +4.1 next day on high-intake days · n 17
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Alcohol+4.1detractor · 95%
- Insoluble fibre-2.3no signal · 51%
- Simple carbohydrates-1.3no signal · 26%
- Dietary fat load-1.1no signal · 18%
- Histamine load-0.5no signal · 15%
- Spicy / capsaicin+0.5no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Autonomic recovery ↓65
- WearableResting HR 75 bpm
- Wearable1,223 steps/day
- WearableShort sleep window
- Inflammatory signalling ↑60
- DNAIL6 -174 variant raises baseline inflammatory tone
- MicrobiomeBacteroides fragilis expansion
- WearableHRV 29 ms, trending down
- Mucosal barrier integrity ↓10
- WearableSleep 5.9 h, below personal baseline
DNA
Fictional pharmacogenomic panel
- IL6 -174 G/CHigher inflammatory tone
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 3.8 · butyrate capacity 51/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumNormal
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 33 ms
- Sleep
- 6.9 h
- Steps
- 3,657
- Resting HR
- 71 bpm
Daily log: GI score 36, nutritional resilience 59, adherence 93.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.